Subscribe now
Amyloidosis involves the build-up of sticky protein

Gene-silencing drug for rare hereditary disorder approved for NHS use

9 July 2019

A therapy that uses RNA interference to treat the rare condition hereditary transthyretin-mediated amyloidosis has been approved for NHS use in England

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop